GlassScriptPhysician profile
Ryan G Deleon
NPI 1538659073
$43,939.21
in general payments reported to CMS, 2019-2025
35 companies · $3,466 in 2025
The $3,466 reported for 2025 was more than what 91% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,576 · 2020: $846 · 2021: $2,760 · 2022: $21K · 2023: $13K · 2024: $1,557 · 2025: $3,466.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $10K · Travel and Lodging: $5,268 · Food and Beverage: $2,472.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $10,000.00 |
| Travel and Lodging | $5,267.51 |
| Food and Beverage | $2,471.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $15,000.00 | 2022 | |
| Arthrex, INC. | $10,474.90 | 2023-2024 | |
| Rock Medical Orthopedics, INC. | $2,975.94 | 2019-2021 | |
| Stryker Corporation | $2,384.89 | 2021-2025 | Ortholoc 2 Lapifuse, Ortholoc 3di, Viaflow |
| Vilex LLC | $1,738.29 | 2023 | |
| Paragon 28, INC. | $1,691.79 | 2021-2022 | |
| In2bones USA, LLC | $1,349.58 | 2022 | |
| Cdc Medical LLC | $1,222.50 | 2022-2024 | |
| Novus Surgical Solutions LLC | $1,200.00 | 2022 | |
| Medline Industries LP | $1,144.78 | 2023-2025 | |
| Legacy Ortho LLC | $973.76 | 2024 | |
| Smith+Nephew, INC. | $682.14 | 2019-2023 | Renasys Go V2 Home, Stravix, Grafix Pl |
| Orthofix Medical, INC. | $631.95 | 2021 | |
| Horizon Therapeutics Plc | $578.91 | 2019-2022 | |
| Kerecis Limited | $465.94 | 2022-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $233.24 | 2022-2023 | Puraply |
| Bioness INC | $137.27 | 2021 | |
| Integra Lifesciences Corporation | $134.71 | 2021 | |
| Bioventus LLC | $127.57 | 2022-2023 | Stimrouter Implantable Kit |
| Wright Medical Technology, INC. | $110.08 | 2019 | |
| Trimed, INC. | $106.01 | 2022 | |
| Globus Medical, INC. | $87.25 | 2021 | |
| Novus Surgical Consultants | $85.91 | 2024-2025 | |
| Medtronic Vascular, INC. | $64.80 | 2019 | |
| Osteomed LLC | $60.04 | 2019 | |
| Arteriocyte Medical Systems, INC. | $55.52 | 2021 | |
| Nevro Corp. | $43.74 | 2022-2023 | Senza |
| Kci USA, INC. | $37.05 | 2019-2022 | |
| Solventum Corporation | $29.05 | 2024-2025 | Prevena, V.A.C.Ulta, Activ.A.C. |
| Dynasplint Systems INC. | $27.76 | 2025 | Dynasplint |
| Boston Scientific Corporation | $25.24 | 2021 | |
| Nabriva Therapeutics, Plc | $19.54 | 2022 | |
| Acell, INC. | $14.86 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $12.42 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $11.78 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Deleon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.